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Abstract
Background: To perform their functions during development and after central nervous system injury, the brain’s
immune cells (microglia) must migrate through dense neuropil and extracellular matrix (ECM), but it is not known
how they degrade the ECM. In several cancer cell lines and peripheral cells, small multi-molecular complexes
(invadopodia in cancer cells, podosomes in nontumor cells) can both adhere to and dissolve the ECM. Podosomes
are tiny multi-molecular structures (0.4 to 1 μm) with a core, rich in F-actin and its regulatory molecules, surrounded
by a ring containing adhesion and structural proteins.
Methods: Using rat microglia, we performed several functional assays: live cell imaging for chemokinesis,
degradation of the ECM component, fibronectin, and chemotactic invasion through Matrigel™, a basement
membrane type of ECM. Fluorescent markers were used with high-resolution microscopy to identify podosomes
and their components.
Results: The fan-shaped lamella at the leading edge of migrating microglia contained a large F-actin-rich
superstructure composed of many tiny (<1 μm) punctae that were adjacent to the substrate, as expected for
cell–matrix contact points. This superstructure (which we call a podonut) was restricted to cells with lamellae, and
conversely almost every lamella contained a podonut. Each podonut comprised hundreds of podosomes, which
could also be seen individually adjacent to the podonut. Microglial podosomes contained hallmark components of
these structures previously seen in several cell types: the plaque protein talin in the ring, and F-actin and
actin-related protein (Arp) 2 in the core. In microglia, podosomes were also enriched in phosphotyrosine residues
and three tyrosine-kinase-regulated proteins: tyrosine kinase substrate with five Src homology 3 domains (Tks5),
phosphorylated caveolin-1, and Nox1 (nicotinamide adenine dinucleotide phosphate oxidase 1). When microglia
expressed podonuts, they were able to degrade the ECM components, fibronectin, and Matrigel™.
Conclusion: The discovery of functional podosomes in microglia has broad implications, because migration of
these innate immune cells is crucial in the developing brain, after damage, and in disease states involving
inflammation and matrix remodeling. Based on the roles of invadosomes in peripheral tissues, we propose that
microglia use these complex structures to adhere to and degrade the ECM for efficient migration.
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Background
Regulated invasion of cells through tissue is crucial for
many physiological processes, including inflammation
and wound healing, but these processes also drive tumor
cell invasion and metastasis [1]; there is thus consider-
able impetus to understand the underlying mechanisms.
As the innate immune cells of the brain, microglia per-
form many roles – from debris clearance to secretion of
growth factors and potentially toxic molecules. Their
capacity to migrate is crucial to both central nervous
system (CNS) development and responses to damage in
the adult brain. For instance, early in development, pre-
cursor cells migrate into the brain parenchyma where
they differentiate into mature microglia [2-4], and
microglia are thought to be replenished throughout life
from invasion of monocyte-lineage cells [5,6]. In the
perinatal period, microglia are amoeboid and highly mi-
gratory [6,7]. In the healthy adult, microglia are ramified
and relatively quiescent but their cell processes continu-
ally extend and retract without overall cell displacement
[4,6,7]. One of the earliest responses to acute CNS in-
jury is microglia translocation to the site of damage [8]
and rapid process extension [6,7]. While conducting
in vivo studies, we were struck by the relatively long
distances over which microglia migrate after optic nerve
transection [9], intracerebral hemorrhage [10] and tran-
sient ischemic stroke [11]. Although microglia migra-
tion has been studied in vitro, in the CNS they must
traverse the densely packed neuropil and extracellular
matrix (ECM) that occupy a large proportion of the
brain volume [12], and the underlying mechanisms are
not known.
Cell migration includes undirected motility (chemo-
kinesis), movement toward a soluble chemoattractant
molecule (chemotaxis) and migration along a gradient of
nonsoluble substrate (haptotaxis). Migrating cells are
polarized along the axis of movement, and often display
a fan-shaped lamella with thin (0.4 to 1.0 μm) protru-
sions (lamellipodia) at the leading edge, and a uropod at
the rear [13]. As a cell advances, newly extended protru-
sions adhere to the extracellular substrate using integ-
rins, while traction force is generated by interaction of
myosin II with actin filaments that are attached through
adaptor proteins to the integrins [14]. The adhesion sites
are reassembled in newly protruded regions and disas-
sembled at the uropod; mechanisms for their rapid turn-
over are therefore needed. In addition, migrating cells
require mechanisms for degrading and remodeling the
ECM, whether they are moving within a tissue or invad-
ing across blood vessels, similar to extravasating immune
cells and metastatic cancer cells.
Some cancer cells were recently found to form invado-
podia, which are small (about 8 × 5 μm) F-actin-rich,
perinuclear structures that are enriched in matrix
metalloproteases, can dissolve the ECM, and are thought
to facilitate cell invasion [15,16]. A related structure in
nontumor cells, the podosome, was described as 0.4 to
1 μm diameter, electron-dense and vinculin-rich mem-
brane protrusions in Src-transformed fibroblasts [17,18],
and in the sealing zone of osteoclasts where these struc-
tures mediate bone resorption [19]. Podosomes are
abundant (100 or more per cell), highly dynamic (turn-
over times of 2 to 12 minutes), and known to degrade
the substrates gelatin and fibronectin [16,20,21]. To-
gether, podosomes and invadopodia are subcellular
structures with the unique ability to adhere to and
degrade the ECM. The present study arose from our
observation that migrating microglia have a large donut-
shaped structure in the lamella at the leading edge,
composed of hundreds of tiny F-actin-rich punctae. We
show that these punctae are individual podosomes,
which express several hallmark molecules in the classical
core and ring arrangement, and that microglia bearing
podosomes can degrade the ECM.
Methods
Cells
All procedures on animals were approved by the Univer-
sity Health Network Animal Care Committee, in accord-
ance with guidelines from the Canadian Council on
Animal Care. Microglia cultures were prepared from 1-
day-old to 2-day-old Sprague–Dawley rat pups (Charles
River, St-Constant, PQ, Canada) using our standard pro-
tocols, which yield ≥99% purity [22,23]. In brief, the
brain was dissected, minced in cold minimal essential
medium (MEM; Invitrogen, Carlsbad, CA, USA), centri-
fuged (300 × g, 10 minutes), and resuspended in MEM
with 10% fetal bovine serum (FBS; Wisent, St-Bruno,
PQ, Canada) and 0.05 mg/ml gentamycin (Invitrogen).
The dissociated cells were then seeded in 75 cm2 flasks
and incubated at 37°C and 5% CO2. After 48 hours the
medium was changed to remove cellular debris and non-
adherent cells, and after a further 4 to 5 days in mixed
culture the microglia were harvested by shaking the
flasks for 2 to 4 hours on an orbital shaker at 65 rpm
(37°C, 5% CO2). After centrifuging the microglia-rich
supernatant (300 × g, 10 minutes), the cell pellet was
resuspended in fresh MEM (with 2% FBS). Microglia
were seeded onto UV-irradiated 15 mm glass coverslips
(Fisher Scientific, Ottawa, ON, Canada) at 50,000 or
60,000 cells per coverslip in 12-well plates, and cultured
for 1 to 2 days in MEM (2% FBS). Importantly, we find
under these growth conditions that the microglia are
relatively resting [24]. In one experiment, microglia were
plated onto Ultra-Web™ (VWR, Mississauga, ON,
Canada), which is a three-dimensional (3D) mesh of
electrospun polyamide nanofibers.
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Live cell imaging
Microglia were plated at 60,000 cells per 35 mm glass-
bottom culture dish (MatTek Corporation, Ashland,
MA, USA), and were cultured for 2 days (MEM, 2%
FBS). Live microglia were imaged for up to 1 hour using
a Zeiss Axiovert 200 M microscope (Zeiss, Toronto, ON,
Canada), an ORCA-ER camera (Hamamatsu Corpor-
ation, Bridgewater, NJ, USA), Axiovision software (Zeiss)
and a Neue LiveCell™ stage top incubator (Pathology
Devices, Westminster, MD, USA) to maintain 37°C and
5% CO2.
Immunocytochemical analysis
Microglia were seeded at 50,000 to 60,000 cells per
15 mm glass coverslip, and were cultured for 2 to 3 days
in MEM with 2% FBS. The standard fixative (except for
nicotinamide adenine dinucleotide phosphate oxidase 1
(Nox1), see below) was 4% paraformaldehyde (Electron Mi-
croscopy Sciences, Hatfield, PA, USA) at room temperature
for 15 minutes. Cells were then permeabilized with 0.2%
Triton X-100 for 5 minutes and washed in PBS (three
times, 5 minutes each), and then nonspecific antigens were
blocked with 4% donkey serum for 1 hour. Because Nox1
antibody stained poorly after paraformaldehyde fixation,
microglia were fixed and permeabilized with HPLC-grade
methanol (5 minutes, –20°C) that had been prechilled over-
night to −40°C. After methanol fixation, F-actin could not
be labeled with phalloidin [25].
All antibodies (Table 1) were diluted in 2.5% donkey
serum and centrifuged before use (8,200 × g, 10 minutes)
to precipitate any aggregated antibody that might be
present. Microglia were incubated with one or two pri-
mary antibodies overnight at 4°C, washed (three times, 5
minutes each) and blocked with 4% donkey serum for 1
hour, and were then incubated with a donkey secondary
antibody for at least 1 hour before washing (three times,
10 minutes each). Negative controls were prepared using
the same protocol, but omitting each primary antibody. F-
actin was visualized by incubating cells (15 minutes, room
temperature in the dark) with Alexa 488-conjugated phal-
loidin (1:50 in blocking solution; Invitrogen). Cell nuclei
were labeled with 4′,6-diamidino-2-phenylindole (1:3,000
in PBS, 5 minutes). After washing (three times, 5 minutes
each), cells on coverslips were mounted on glass slides ei-
ther with 50% glycerol in PBS, which produced the lowest
background, or with VectaShield™ (Vector Labs, Burling-
ton, CA, USA) or Dako mounting medium (Dako,
Glostrup, Denmark), which yielded more stable signals for
longer imaging (Z-stacks).
Images were acquired with an Axioplan 2 widefield
epifluorescence microscope equipped with an Axiocam
HRm digital camera, and were analyzed with Axiovision
4.6 software (all Zeiss) or ImageJ (version 1.41o [26]).
For many images, we acquired Z-stacks through the en-
tire cell (that is, high-magnification epifluorescence
images through the Z-axis at 200 nm increments). These
images were then deconvolved using a theoretical point
spread function and the constrained iterative maximum-
likelihood algorithm in Axiovision 4.7 software (Zeiss).
3D reconstructions were made with Imaris software (Bit-
plane Scientific Software, Zurich, Switzerland). Deconvo-
lution reduces noise and distortions introduced during
image acquisition by using information about the optical
system; that is, the type of objective lens, the refractory
index of the immersion medium, and the point spread
function of light above and below the plane of focus
(reviewed in [27]). Cell autofluorescence and nonspecific
staining were subtracted using the same imaging and
acquisition settings on cells exposed to secondary
antibodies alone. When constructing Z-stacks, the
Table 1 Antibodies and stains used
Antibody/stain (species, type) Concentration Source
Phalloidin 488 or 350 (labels F-actin) 1:50 Invitrogen (Carlsbad, CA, USA)
DAPI (4′,6-Diamidino-2-phenylindole; labels DNA) 1:3,000 Invitrogen
Talin1/2 (mouse monoclonal) 1:100 Abcam (Cambridge, MA, USA)
Arp2 (actin-related protein 2) (rabbit polyclonal) 1:100 Santa Cruz Biotechnology (Santa Cruz, CA, USA)
Tks5 (tyrosine kinase substrate with five Src homology 3
domains) (rabbit polyclonal)
1:100 Santa Cruz Biotechnology
Phospho-caveolin 1 (p-Tyr14Cav1) 1:100 Signalway Antibody
(rabbit polyclonal) (Pearland, TX, USA)
Anti-phosphotyrosine (mouse monoclonal) 1:100 Abcam
Nox1 (nicotinamide adenine dinucleotide phosphate
oxidase 1) (goat polyclonal)
1:100 Santa Cruz Biotechnology
DyLight donkey anti-rabbit 488 or 594 (secondary) 1:250 Jackson Immunoresearch (West Grove, PA, USA)
DyLight donkey anti-mouse 488 or 594 (secondary) 1:250 Jackson Immunoresearch
Donkey anti-goat FITC (secondary) 1:250 Jackson Immunoresearch
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automated correction algorithm was used to compensate
for fluorescence decay during repeated exposures.
Chemotaxis, substrate degradation and invasion assays
Chemotaxis
Microglia were suspended in MEM with 2% FBS, and
150 μl cell suspension (2 × 104 cells) was added to the
upper well of each Transwell™ insert (VWR), which had
an uncoated filter bearing pores 8.0 μm in diameter. The
lower well contained MEM with 2% FBS, with or with-
out 300 μM ATP. The entire chamber was incubated for
24 hours (37°C, 5% CO2). Microglia on the upper side of
each filter were removed with a Q-tip, and then the filter
was fixed in 4% paraformaldehyde, rinsed with PBS,
stained with 0.5% crystal violet for 2 minutes, and again
rinsed with PBS. The number of cells that had migrated
to the underside was counted (five fields per filter) under
phase contrast at 40× magnification using an Olympus
CK2 inverted microscope (Olympus, Tokyo, Japan).
Substrate degradation
The most common assay for studying ECM degradation
by podosomes (and invadopodia) employs fluorescent-
labeled fibronectin, either coated directly onto glass
coverslips or on a layer of gelatin. ECM degradation is
monitored as loss of fluorescence. We labeled bovine fibro-
nectin (Sigma-Aldrich) using the AlexaFluor 488 Protein
Labeling Kit (Invitrogen), after which the conjugated
protein was separated from unconjugated dye on a
column. Purified AlexaFluor 488-conjugated fibronectin
was diluted in PBS (~2 μg/ml) and incubated with glass
coverslips (150 μl per slip overnight at 37°C). After the
solution was aspirated off, microglia were seeded onto
the fibronectin-coated coverslips (50,000 cells per cover-
slip) and incubated for 2.5 to 24 hours. In some experi-
ments, 0.04% Trypan Blue dye (Invitrogen) in PBS was
added to quench extracellular fluorescence. Fixation and
staining then proceeded as described earlier in Immuno-
cytochemical analysis.
Invasion
Microglial invasion through a basement membrane type
of ECM (Matrigel™, which is secreted by mouse sarcoma
cells) was quantified using 24-well BD BioCoat Matrigel™
Invasion Chambers (BD Biosciences, Mississauga, ON,
Canada). The filters, which bore pores 8.0 μm in diam-
eter coated with Matrigel™, were rehydrated for 1 hour
at 37°C with 500 μl medium (MEM, 2% FBS). The solu-
tion was then replaced with 500 μl fresh MEM (with 2%
FBS) containing 2 × 104 microglia. The lower well of
each chamber contained 500 μl medium (MEM, 2%
FBS), with or without 300 μM ATP. Microglia were
incubated (24 hours, 37°C, 5% CO2) and counted as
above (see Chemotaxis).
Statistical analysis
Quantitative data are presented as the mean ± standard
error of the mean. One-way analysis of variance was fol-
lowed by a post-hoc Tukey’s test, and results are consid-
ered significant if P < 0.05.
Results
Cultured rat microglia display chemokinesis, chemotaxis
and invasion
Immune cells can migrate by chemokinesis, chemotaxis
or haptotaxis [13]; however, substrate degradation is an
additional requirement for migration through basement
membranes and the ECM. We found that untreated rat
microglial cells under our standard culture conditions
were highly migratory on glass coverslips. All microglia
undergoing migration were polarized, with a fan-shaped
lamella (Figure 1A,B,C) that was in constant motion, ruf-
fling across the glass. Individual cells alternated between
a migratory state, with lamellae and processes extended,
and a nonmobile state with a condensed cell body, no
lamella and often a bipolar appearance. Within 10 minutes
after a lamella was observed, >35% of the microglia
migrated and always in the direction of the lamella. Within
a 30-minute period, some microglia changed direction but
only after extending a new lamella at a different location
and migrating in the direction of that lamella. Microglia
that lacked a lamella (for example, bipolar cells) did not
migrate during a 45-minute observation period. Within
each lamella, a large, ring-like structure could often been
seen under phase-contrast microscopy (Figure 1B). In
addition to migrating along glass, microglia effectively
trans-migrated (in three dimensions) through holes of
8 μm diameter in filters in the upper well of Transwell™
chambers, and displayed chemotaxis in response to ATP
added to the lower well (Figure 1D). Importantly, microglia
invaded to the underside of BioCoat Matrigel™ Invasion
chambers, a process that requires degradation of Matrigel™,
which coated the filter holes. Invasion was stimulated by
an ATP gradient (Figure 1E).
Microglia lamellae express podosomes and a podosome
superstructure
Phalloidin toxin staining of filamentous actin (F-actin)
revealed a large donut-shaped ring in the lamella at the
leading edge of most migrating microglia (Figure 2A).
Higher-resolution deconvolved images (Figure 2B,E)
show that this large F-actin ring is comprised of many
submicron-sized punctae (which we found are podo-
somes, see below). Such F-actin-rich punctae were
detected in 87 ± 5% of microglia that bore a lamella
(Figure 2C), and when present the punctae were localized
to the lamella (96 ± 2%; Figure 2D). Deconvolved images
and 3D projections showed that the punctae were
located near the substrate-contacting surface (Figure 2E).
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Expression of the large F-actin ring was not restricted to
microglia growing on a glass substrate; it was prevalent
in cells growing on a 3D mesh of polyamide nanofibers
(Ultra-Web™; Figure 2F). However, because the imaging
and deconvolution were not as clear on Ultra-Web™, the
remaining immunocytochemistry was conducted on
microglia growing on glass.
Small F-actin punctae are characteristic of both podo-
somes and the larger invadopodia, and distinguish them
from other cell–matrix contacts, such as focal adhesion
complexes [15]. In podosomes, the F-actin-rich core
contains regulatory molecules (for example, the actin
nucleator actin-related protein (Arp)2) and is sur-
rounded by a ring containing structural proteins (for ex-
ample, the plaque protein talin) [16,28] (see Discussion).
In addition to F-actin, the large podosome superstruc-
ture in microglia (which we call a podonut) was enriched
in talin (Figure 3A) and Arp2 (Figure 3B) staining. High-
resolution deconvolution imaging showed that individual
podosomes were tiny circular structures (0.5 to 1 μm
diameter) with an F-actin core surrounded by a ring of
talin, or a core of Arp2 surrounded by talin. We then
quantified the prevalence of podosome expression by
staining for F-actin and talin, and analyzing images at
≥40× magnification. Podosomes were detected in
48 ± 10% of microglia after at least 2 days of culturing,
and 30 ± 9% of cells expressed >100 podosomes
(Figure 3C). Microglia expressing >100 podosomes typic-
ally displayed the large F-actin-rich podonut in the la-
mella, while those with fewer podosomes had a more
scattered distribution throughout the lamella or in other
small membrane extensions.
Microglial podosomes express several tyrosine
phosphorylation-regulated components
Podosome formation is stimulated by Src tyrosine kin-
ase, and many components of podosomes and invadopo-
dia are regulated by tyrosine phosphorylation (see
Discussion); staining for phosphotyrosine (pTyr) is
therefore often high in these structures. We found
enriched pTyr staining in a punctate pattern at the lead-
ing edge of polarized microglia, and in the podonut
(Figure 4A). At high resolution, pTyr labeling was round
or elongated, some co-localized with the punctae of F-
actin staining in the podosome core and some present
adjacent to F-actin, suggesting localization to the ring as
well. Outside the podonut, small punctae of pTyr stain-
ing were seen throughout the lamella.
One substrate of Src-mediated phosphorylation is
tyrosine kinase substrate with five Src homology 3
domains (Tks5), which is enriched in invadopodia and
podosomes in a few cell types [29,30] and is thought to act

















































Figure 1 Cultured rat microglia display chemokinesis,
chemotaxis, and invasion. (A) To monitor chemokinesis (random
migration) in two dimensions, cultured rat microglia were imaged
for 45 minutes under phase-contrast microscopy at 37°C and 5%
CO2. A representative video frame capture, in which the numbered
cells were tracked and analyzed (results in (c)). Inset: higher-
magnification images show a lamella and extension of the leading
edge in a migrating cell, but not in an immobile bipolar microglial
cell. Scale bar: 80 μm (upper image), 40 μm (lower image). (B)
Higher-magnification phase-contrast image showing a large ring-like
structure in the lamella (circled), and a uropod at the trailing edge
(arrow). Scale bar: 20 μm. (C) Each of the 28 microglial cells marked
in (a) had a lamella at some time during the monitoring period.
During a 10-minute examination period, these cells were classified
as migrating in the direction of the lamella, in the opposite
direction, or not moving. (D) Quantification of microglia
transmigration through pores of 8 μm diameter in filters in the
upper well of Transwell™ chambers. Microglia displayed chemotaxis
toward 300 μM ATP added to the lower well. Values on bars are
mean± standard error of the mean (SEM) (n= 5). (E) Microglia
invaded through Matrigel™-coated pores in the BioCoat Matrigel™
Invasion chambers, and invasion was increased by adding 300 μM
ATP to the lower well. Values on bars are mean± SEM (n= 6).
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In microglia, Tks5 staining was enriched in podonuts and
at high magnification appeared as small punctae, often in
a ring-like arrangement and adjacent to talin (Figure 4B).
Tks5 was also present in small punctae outside the
podonut and throughout the lamella.
Caveolin-1 (Cav1) is a major structural protein of
caveolae [1], and can be phosphorylated at tyrosine 14
by Src-family kinases, including c-Src, Lyn and Hck
[31,32]. p-Tyr14Cav1 was seen in podosomes in an














































Figure 2 Lamellae in microglia have a large F-actin ring, comprised of many small punctae. F-actin was labeled with phalloidin (green) in
all images. (A) Low-magnification image of many migrating microglia on a glass coverslip. Most lamellae have a large, donut-shaped F-actin ring
(* indicates examples), which we call a podonut. Scale bar: 40 μm. (B) Higher-magnification, deconvolved image shows a podonut in the front
half of a migrating microglial cell. Scale bar: 10 μm. (C), (D) F-actin rings were predominantly associated with microglial lamellae. Values expressed
as mean± standard error of the mean from three separate cultures. Most microglia with a lamella had a large F-actin ring (a podonut) (87 ± 5% of
such cells (c)). As further demonstrated in Figure 3, the large ring was made up of many podosomes. When podosomes were present, they (and
the large F-actin ring) were located in the lamella (95 ± 2% of such cells (d)). (E) The large F-actin rings contain hundreds of tiny punctae of
F-actin. A representative deconvolved image of a single podonut shows that the large ring is composed of many tiny (<1 μm diameter)
F-actin-rich punctae. Scale bar: 5 μm. Inset: a deconvolved three-dimensional (3D) reconstruction shows that the punctae of F-actin were located
near the substrate-contacting cell membrane. (F) Microglia formed similar large, F-actin rings in their lamellae; nuclei stained with 4′,6-diamidino-
2-phenylindole, (DAPI, blue) when cultured on Ultra-Web™, which is a 3D mesh of polyamide nanofibers (upper image). Right: higher
magnification image of several microglia with large F-actin rings. Scale bar: 100 μm (left), 20 μm (right).
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Figure 3 The F-actin-rich punctae are podosomes. (A) Microglia were stained for F-actin (phalloidin, green), the plaque protein talin (red), and
the nuclear stain 4′,6-diamidino-2-phenylindole (DAPI; blue). A representative image of the large F-actin ring (podonut) in front of the nucleus
shows co-localization with talin. Scale bar: 5 μm. Right: higher-magnification deconvolved images of the two boxed regions, color-separated and
merged to show that the dense F-actin ring is comprised of many tiny punctae of F-actin and talin. Individual podosomes are seen as a core of
F-actin, surrounded by a ring of talin (arrows show examples). Scale bar: 1 μm. (B) Microglia were immunostained for the plaque protein, talin
(green), the actin nucleator actin-related protein 2 (Arp2; red), and labeled with the nuclear stain DAPI (blue). Arp2 is enriched in the podosome
core, and the plaque protein talin identifies the ring. Lower image: under phase contrast, podosomes were often seen as dark punctae. (C)
Prevalence of podosome expression in primary microglia (that is, percentage of cells with podosomes); >65 cells were analyzed per replicate
from each of three cultures (mean± standard error of the mean).
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microglia, p-Tyr14Cav1 was enriched in the podonut,
and within individual podosomes it was in a ring-like
pattern, closely associated with talin (Figure 5A).
Finally, we analyzed the distribution of Nox1 because
of recent evidence that it is present in invadopodia and
required for their formation in colon cancer cells [30]
and that Nox1 is regulated by Src and Tks5 [34,35].
Nox1 was enriched in microglia podonuts, and at higher
magnification appeared elongated and adjacent to, but
rarely overlapping with, the talin staining (Figure 5B).
Microglia with podosomes can degrade extracellular
matrix molecules
The key function usually ascribed to podosomes is ECM
degradation, and the invasion assay (Figure 1E) shows
that microglia can degrade Matrigel™. We next employed
the standard test for podosome functionality, which is
degradation of fluorescent-labeled substrate (fibronectin
or gelatin) and consequent loss of fluorescence [21,36].
First, we determined that podonuts developed between
10 and 20 hours after cell plating, as seen from the F-
actin staining (Figure 6A). This delay is not surprising,
because microglia round up after being removed from
the tissue culture flask and require some time before
extending processes and becoming migratory (that is,
10 to 20 hours). To directly demonstrate substrate
degradation, we then added microglia onto coverslips
that were coated with a thin layer of fluorescent-
labeled fibronectin, and incubated them for 2.5 to 20
hours. Fibronectin degradation produced many cell-
sized regions of reduced fluorescence at 20 hours









Figure 4 Microglial podosomes are enriched in phosphotyrosine and the Src substrate Tks5. Deconvolved, color-separated and merged
images of entire podonuts are shown in the upper panels, and the boxed areas are shown magnified and color-separated below. Scale bar: 5 μm
(upper), 2 μm (lower). (A) Immunostaining for phosphotyrosine residues (pTyr, red) is enriched in the F-actin-rich podonut (labeled with
phalloidin, green). At higher magnification, some co-localization is seen. (B) Immunostaining shows tyrosine kinase substrate with five Src
homology 3 domains (Tks5; green) in microglia podosomes together with the ring marker talin (red). The small punctae of Tks5 are often
adjacent to the talin staining.
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There was no degradation at 20 hours without micro-
glia or at 2.5 hours with microglia. In the example
shown at higher magnification (Figure 6C), three
regions of fibronectin degradation (fluorescence loss)
at 20 hours corresponded in size, shape and position
to microglia.
Microglia plated on fibronectin often displayed a
podonut or large clusters of podosomes that stained
with F-actin and talin (Figure 7). Because our live im-
aging showed that microglia are highly mobile
(Figure 1C,D,E) and podosomes have a high turnover rate
(see Discussion), it was not surprising to observe trails
Figure 5 Microglial podosomes are enriched in Tyr14-phosphorylated caveolin-1 and nicotinamide adenine dinucleotide phosphate
oxidase 1(Nox1). Deconvolved, color-separated and merged images of the lamellar region are shown for two microglia. The boxed areas are
magnified in the images at the bottom. Scale bar: 5 μm (upper), 2 μm (lower). (A) Immunolabeling for tyrosine-phosphorylated caveolin-1
(p-Tyr14Cav1; green) and the podosome ring marker talin (red). (B) Immunolabeling for Nox1 (green) and talin (red). Note: Nox1 staining required
methanol fixation.
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of fibronectin degradation (Figure 7A). Some microglia
were apparently less mobile, making it possible to correl-
ate podosome clusters with similar-sized punctae of
fibronectin degradation (Figure 7B). Importantly, we
determined that loss of fluorescent fibronectin was not
due to phagocytosis by microglia. That is, after adding
Trypan Blue to quench the extracellular fluorescence,
regions of remaining fluorescence were associated
with cell bodies but the fluorescence signal was at the
substrate–glass interface, not inside the microglia
(Figure 7C). (Note: brighter fluorescence under the ad-
herent cells was expected because of reduced access for
the quenching agent, Trypan Blue.)
Discussion
Microglial migration to sites of CNS damage is widely
observed; however, the mechanisms regulating the ability
of microglia to migrate through the neuropil and ECM
are poorly understood. There are several salient findings
in this study. Cultured rat microglia displayed spontan-
eous migration (chemokinesis) on bare or fibronectin-
coated glass and a 3D mesh of polyamide nanofibers
(Ultraweb™), and underwent ATP-stimulated chemotaxis
through open or Matrigel™-coated filter holes. A second
finding was that migrating microglia were polarized
along the axis of movement, with a thin fan-shaped la-
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Figure 6 Microglia with podosomes degrade the extracellular matrix molecule fibronectin. (A) Development of F-actin superstructures
(podonuts) with time after plating microglia on coverslips. Upper panels: microglia were labeled for the podosome core component F-actin
(phalloidin, red). Podonuts in the lamellae were prevalent after 20 hours of culturing (examples shown by arrows), but not after 2.5 or 10 hours.
Lower panels: higher-magnification grayscale images of the boxed regions. Scale bar: 40 μm (upper), 20 μm (lower). (B) Panels indicate the
control condition at 20 hours without microglia (left), or 2.5 and 20 hours after adding microglia. Microglia were labeled for F-actin (phalloidin,
red), and the substrate, fibronectin, was conjugated to AlexaFluor 488 (green). Representative images from three separate experiments. Scale bar:
40 μm. (C) Higher-magnification, color-separated and merged images showing microglia-sized areas of fibronectin degradation. Stains for F-actin
and fibronectin were as in (b), and microglial nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI, blue). Scale bar: 10 μm.
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the lamella contained a large F-actin-rich ring that was
readily detected by staining with fluorescent phalloidin.
Another finding was that each large ring was comprised
of many small punctae (<1 μm diameter), which we
showed to be classical podosomes having a core with F-
actin and the F-actin nucleator, Arp2/3, surrounded by a
ring of the structural protein talin. Podosomes in micro-
glia were restricted to the lamella region, and were near
the cell–substrate interface. The study also found that
podosomes and their superstructures (podonuts) were
readily detected in microglia growing on bare glass, a
synthetic 3D mesh, or fibronectin. A fifth finding was
that microglial podonuts and podosomes were also
enriched in tyrosine-phosphorylated proteins and several
molecules that are regulated by tyrosine kinases (Tks5,
Cav1 and Nox1). Finally, podosomes formed in microglia
within 20 hours after plating on fibronectin, at which
time they degraded this ECM component; no degrad-
ation was seen at earlier times, however, when podonuts
were lacking. At low magnification, fibronectin degrad-
ation often appeared as loss of fluorescence in cell-sized
patches. At high magnification, fluorescence loss was
seen as podosome-sized punctae (~1 μm) and trails of
such punctae were seen, presumably occurring as micro-
glia simultaneously migrated and degraded the fluores-
cent fibronectin.
Microglia undergo chemotaxis in vitro, responding to
gradients of ATP, glutamate, and chemokines, such as
CCL21 [37-39] – chemoattractants that are also thought






Figure 7 Fibronectin degradation corresponds with podosomes. (A) Microglia labeled with the podosome ring component, talin, showing
two large clusters of podosomes (arrows). The cell at the right has a large ring of talin (a podonut). Fibronectin degradation (as in Figure 6) is
indicated by loss of fluorescence (note: for better contrast, the AlexaFluor 488 was pseudo-colored as blue). Scale bar: 10 μm. (B) Co-localization
of podosomes labeled for F-actin (phalloidin, red) with punctate regions of reduced fibronectin, labeled with AlexaFluor 488 (green). Left:
combined phase-contrast and fluorescence image of the front of a microglia (nucleus is smooth circle), stained for F-actin (phalloidin), showing
the podosome-rich lamella (boxed area). The colored images of the boxed area show F-actin, and the merged image with AlexaFluor 488-labeled
fibronectin. Scale bar: 5 μm. (C) Fibronectin loss is not by phagocytosis. A high-resolution, deconvolved three-dimensional projection shows that
punctae of fibronectin staining (green) are adjacent to the glass, rather than inside the microglia (4′,6-diamidino-2-phenylindole-stained nuclei,
DAPI, blue). Scale bar: 10 μm.
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[7]). Their ability to migrate can also be affected by
ECM changes that occur after damage or disease. In the
healthy adult CNS, the ECM (also called the peri-
neuronal net) has high expression of glycosaminoglycans
with unbranched polysaccharide chains that form space-
occupying hydrated gels [40], as well as sulfated proteo-
glycans and tenascin glycoproteins [41]. The location of
fibrous and elastic components is more restricted in the
CNS; for example, fibronectin is mainly in the cerebro-
vasculature [42], and collagen is in basement membranes
of the cerebrovasculature, dura mater and leptomeninges
[41,43,44]. In addition, there are secreted matricellular
proteins that are involved in cell–matrix interactions
and signaling [12]. When the CNS is damaged, changes
occur in the ECM and matricellular molecules. For in-
stance, the matrix protein tenascin-R, which is anti-
adhesive for activated microglia, is downregulated, which
is thought to allow microglia to migrate into the injured
site [45]. We recently reported that the anti-adhesive
matricellular molecule SC1/hevin is upregulated in
astrocytes and damaged axons in models of ischemic
and hemorrhagic stroke [46]. Other expected changes
after acute injury are disruption of the blood–brain
barrier, edema, increased ECM hydration, and entry
of plasma matrix proteins, including fibronectin and
vitronectin [47]. Surprisingly, it is not known how
microglia penetrate the ECM of either the healthy or
damaged CNS.
In the 1980s, podosomes and invadopodia (often col-
lectively called invadosomes) were identified and shown
to possess the unique ability to both adhere to and de-
grade ECM components. These small, punctate struc-
tures at the ventral cell surface [17,18,28] differ from
other cell adhesion structures in composition, architec-
ture, dynamics and functions, and are now thought to
contribute to cellular invasion in normal and patho-
logical conditions (recently reviewed in [16,20,21,48]).
Invadopodia in cancer cells appear as a small number of
irregular punctae (~8 × 5 μm) near the nucleus and
Golgi complex that can be stable for more than 1 hour
[15,21]. Podosomes in cell lines [17,18,29,49] and the
few normal cell types in which they have been found
[50-52] are smaller (~0.4 × 1 μm), more numerous (often
>100 per cell), more dynamic (lifetime of only a few
minutes), and are sometimes in structured arrays
[20,21]. Podosomes were recently seen in vitro in 3D
cultures of macrophages [53] and transforming growth
factor beta-stimulated endothelial cells [54], and in vas-
cular smooth muscle cells of artery vessel walls in vivo
[51]. The first evidence that podosomes degrade matrix
was that osteoclasts from Src knockout mice lacked
podosomes and the ability to resorb bone [55], and
later it was found that loss of the podosome component
Wiskott–Aldrich Syndrome protein prevented podosome
formation [56] and matrix degradation [57,58]. Crucial
signals for invadosome formation are cell attachment to
a substrate [15,28], interactions between integrins and
the ECM, and intracellular signaling initiated by acti-
vated Src [15,21], which is considered the key orchestra-
tor. For instance, expressing constitutively active Src
causes fibroblasts to express podosomes [16-18,48,59],
while Src inhibition disrupts podosome formation in
osteoclasts and macrophages [16,60,61]; conversely, inhi-
biting tyrosine phosphatases induces podosome forma-
tion in fibroblasts and monocytes [16,62]. Cells of
myeloid lineage are apparently unique in their capacity
to form podosomes spontaneously following cell adhe-
sion [63,64], as was the case for microglia in the pre-
sent study.
As sites of complex signal integration, invadosomes
are enriched in many molecules. However, the current
information derives from only a few cell types, and it is
not clear whether the molecular profile reflects the tis-
sue origin. For instance, gelsolin is apparently required
for podosome formation in osteoclasts [48] but not in
dendritic cells [65]. Podosomes are distinguished by their
two-part architecture, with an F-actin-rich core sur-
rounded by a prominent ring containing cell-type spe-
cific integrins [27,66] that anchor the podosome to ECM
components (for example, fibronectin, vitronectin) [48]
and adhesion-plaque proteins (talin, vinculin, paxillin)
that link integrins to the actin cytoskeleton [67]. F-actin
is important for podosome formation, and the core con-
tains many actin regulatory molecules; that is, nucleators
(Arp2/3 complex, formins), binding proteins (coronin,
tropomyosin), filament crosslinkers (caldesmon,
α-actinin) and polymerization activators (cortactin,
Wiskott–Aldrich syndrome protein and its regulators)
[16,48,63,64,66]. The most commonly used markers to
identify podosomes are F-actin, talin, vinculin and
Arp2/3 [16,28,48]. We found that podosomes in micro-
glia had a classical structure; that is, they were tiny punc-
tae (<1 μm diameter) present at the ventral cell surface,
with a core containing F-actin and Arp2 and a ring con-
taining talin. While podosomes are typically reported as
isolated structures, we nearly always observed a super-
structure (podonut) in the lamella in migrating microglia.
This structure differs from osteoclasts, in which a belt of
podosomes along the entire outer edge forms a sealing
zone into which protons and proteases are secreted for
bone resorption [68,69].
Tyrosine phosphorylation plays a central role in inva-
dosomes, which are enriched in pTyr residues, protein
tyrosine kinases (Src, Csk, Cbl, Pyk2) and adapter pro-
teins (Tks5, Nck1, Nck2). After integrins are activated,
Src can phosphorylate and activate other substrates
[28] – including Tks5, which is one of the orchestrators
of podosome formation [29,30,70]. Tks5 has previously
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been reported in invadopodia, but only in podosomes of
phorbol ester-stimulated smooth muscle cells and myo-
blasts [71,72]. Tks5 can associate with cytoskeletal regulat-
ing proteins (neural Wiskott–Aldrich syndrome protein,
dynamin, focal adhesion kinase) [73], dystroglycan [71],
and matrix-degrading proteins (ADAMS-12, ADAMS-15
and ADAMS-19 [29], matrix metalloproteinase-9 [70]).
In microglia, we found enrichment of pTyr residues and
Tks5 in podonuts and individual podosomes; and while
Tks5 was often adjacent to talin, it was also seen in other
cellular locations. Another notable Src substrate is Cav1
[32,74], which can be phosphorylated at Tyr14 in response
to growth factor signaling or oxidative stress [75,76],
and can then regulate turnover of focal adhesions [77].
We found that the ring of podosomes in microglia was
enriched in p-Tyr14Cav1. Cav1 has only been reported in
invadopodia in three cell lines; that is, the nonpho-
sphorylated form in two cancer cell lines [78,79], and the
phosphorylated form in an ACTH-stimulated adrenal
cell line [33]. Nox1 generates reactive oxygen species,
which can activate protein kinases and inhibit protein
tyrosine phosphatases [80]. Nox1 was found in invadopo-
dia in human colon cancer cells [81,82], and its inhib-
ition disrupted invadopodia formation [35,81]. Here, we
show that Nox1 is enriched in microglial podosomes,
which is especially notable because we have previously
shown that reactive oxygen species production is a key
mechanism whereby Kv1.3, SK3 and SK4 potassium
channels control the capacity of activated microglia to
kill neurons [22,23,83].
Conclusion
Migrating microglia have a lamella that contains multi-
molecular podosome structures and superstructures that
can degrade components of the ECM. Microglial podo-
somes express several hallmark molecules seen in the
few cell types in which they have been previously
observed. The existence of podosomes in microglia has
broad implications and might explain how these cells
can migrate through the dense ECM in the brain; for ex-
ample, in the developing brain, after damage, or in dis-
ease states when there is inflammation and matrix
remodeling. In future, podosomes and their components
might provide targets for diseases in which microglial
accumulation is associated with negative outcomes; for
example, stroke, hemorrhage, trauma, and spinal cord
injury. The prospects are especially good because cancer
cell invadopodia have several of the same molecules that
are already being targeted for developing therapeutics.
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